Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic & Testing Substances
- Sub-Industry: N/A
- Symbol: NASDAQ:QTNT
- CUSIP: N/A
- Web: www.quotientbd.com
Capitalization:- Market Cap: $48.45 million
- Outstanding Shares: 14,376,000
Average Prices:- 50 Day Moving Avg: $5.82
- 200 Day Moving Avg: $6.59
- 52 Week Range: $3.33 - $8.64
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.38
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $23.34 million
- Price / Sales: 2.08
- Book Value: $0.12 per share
- Price / Book: 28.08
Profitability:- EBIDTA: ($64,950,000.00)
- Net Margins: -381.66%
- Return on Equity: -13,050.41%
- Return on Assets: -75.08%
Debt:- Debt-to-Equity Ratio: 18.58%
- Current Ratio: 2.23%
- Quick Ratio: 1.71%
Misc:- Average Volume: 214,159 shs.
- Beta: 1.31
- Short Ratio: 6.42
Frequently Asked Questions for Quotient Limited (NASDAQ:QTNT)
What is Quotient Limited's stock symbol?
Quotient Limited trades on the NASDAQ under the ticker symbol "QTNT."
How were Quotient Limited's earnings last quarter?
Quotient Limited (NASDAQ:QTNT) released its earnings results on Monday, August, 7th. The company reported ($0.55) EPS for the quarter, hitting analysts' consensus estimates of ($0.55). The firm had revenue of $6.83 million for the quarter, compared to analysts' expectations of $5.70 million. Quotient Limited had a negative return on equity of 13,050.41% and a negative net margin of 381.66%. View Quotient Limited's Earnings History.
When will Quotient Limited make its next earnings announcement?
Where is Quotient Limited's stock going? Where will Quotient Limited's stock price be in 2017?
2 brokers have issued 12 month target prices for Quotient Limited's stock. Their forecasts range from $16.00 to $22.00. On average, they expect Quotient Limited's stock price to reach $19.00 in the next twelve months. View Analyst Ratings for Quotient Limited.
Who are some of Quotient Limited's key competitors?
Some companies that are related to Quotient Limited include Alimera Sciences (ALIM), Genesis Healthcare (GEN), Agile Therapeutics (AGRX), MEI Pharma (MEIP), CytRx Corporation (CYTR), Intec Pharma (NTEC), Galmed Pharmaceuticals (GLMD), GTx (GTXI), Affimed N.V. (AFMD), Cardiome Pharma Corporation (CRME), Regulus Therapeutics (RGLS), Lipocine (LPCN), ContraFect Corporation (CFRX), Applied Genetic Technologies Corporation (AGTC), Zynerba Pharmaceuticals (ZYNE), Gemphire Therapeutics (GEMP), Verona Pharma PLC American Depositary Share (VRNA) and ProNAi Therapeutics (SRRA).
Who are Quotient Limited's key executives?
Quotient Limited's management team includes the folowing people:
- Paul E. Cowan, Chairman of the Board, Chief Executive Officer
- Edward Farrell, President
- Jeremy Stackawitz, President
- Christopher J. Lindop, Chief Financial Officer, Principal Financial Officer
- Roland Boyd, Group Financial Controller, Treasurer, Principal Accounting Officer
- Heino von Prondzynski, Lead Independent Director
- Sarah A. O'Connor, Director
- Zubeen Shroff, Director
- John Wilkerson, Director
- Thomas A. Bologna, Independent Director
Who owns Quotient Limited stock?
Quotient Limited's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Ameriprise Financial Inc. (12.73%), Northern Trust Corp (1.68%), State Street Corp (1.63%), FNY Partners Fund LP (0.90%), Scholtz & Company LLC (0.89%) and Birchview Capital LP (0.55%). Company insiders that own Quotient Limited stock include D J Paul E Cowan, Jeremy Stackawitz, L John Wilkerson, Stephen Unger and Zubeen Shroff. View Institutional Ownership Trends for Quotient Limited.
Who bought Quotient Limited stock? Who is buying Quotient Limited stock?
Quotient Limited's stock was acquired by a variety of institutional investors in the last quarter, including Northern Trust Corp, State Street Corp, Scholtz & Company LLC, Ameriprise Financial Inc., Vanguard Group Inc., TIAA CREF Investment Management LLC, Bank of New York Mellon Corp and California State Teachers Retirement System. Company insiders that have bought Quotient Limited stock in the last two years include D J Paul E Cowan, L John Wilkerson and Zubeen Shroff. View Insider Buying and Selling for Quotient Limited.
How do I buy Quotient Limited stock?
Shares of Quotient Limited can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Quotient Limited's stock price today?
One share of Quotient Limited stock can currently be purchased for approximately $3.37.
MarketBeat Community Rating for Quotient Limited (NASDAQ QTNT)MarketBeat's community ratings are surveys of what our community members think about Quotient Limited and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Quotient Limited (NASDAQ:QTNT) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $19.00 (463.80% upside) |
Analysts' Ratings History for Quotient Limited (NASDAQ:QTNT)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/18/2017 | BTIG Research | Reiterated Rating | Buy | $22.00 | High |  |
| 1/6/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $16.00 | N/A | |
(Data available from 8/21/2015 forward)
Earnings History for Quotient Limited (NASDAQ:QTNT)Earnings History by Quarter for Quotient Limited (NASDAQ QTNT)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | | | | | | | |
| 8/7/2017 | Q1 2018 | ($0.55) | ($0.55) | $5.70 million | $6.83 million | View | Listen | |
| 5/22/2017 | Q4 | ($0.76) | ($0.69) | $4.30 million | $5.53 million | View | N/A | |
| 2/6/2017 | 12/31/2016 | ($0.56) | ($1.06) | $4.50 million | $4.84 million | View | Listen | |
| 5/23/2016 | Q4 | ($0.59) | ($0.41) | $5.00 million | $5.05 million | View | N/A | |
| 2/8/2016 | Q316 | ($0.76) | ($0.48) | $4.06 million | $4.35 million | View | N/A | |
| 11/2/2015 | Q216 | ($0.80) | ($0.25) | $4.42 million | $4.27 million | View | N/A | |
| 8/3/2015 | Q116 | ($0.67) | ($0.60) | $4.90 million | $4.85 million | View | N/A | |
| 5/18/2015 | Q415 | ($0.52) | ($0.77) | $4.39 million | $3.90 million | View | N/A | |
| 2/2/2015 | | ($0.68) | ($0.51) | $4.26 million | $4.06 million | View | N/A | |
| 11/3/2014 | | ($0.58) | ($0.82) | $4.62 million | $4.53 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Quotient Limited (NASDAQ:QTNT)2017 EPS Consensus Estimate: ($2.64)
2018 EPS Consensus Estimate: ($2.11)
2019 EPS Consensus Estimate: ($1.15)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.71) | ($0.71) | ($0.71) |
| Q2 2017 | 1 | ($0.64) | ($0.64) | ($0.64) |
| Q3 2017 | 1 | ($0.62) | ($0.62) | ($0.62) |
| Q4 2017 | 1 | ($0.67) | ($0.67) | ($0.67) |
| Q1 2018 | 1 | ($0.56) | ($0.56) | ($0.56) |
| Q2 2018 | 1 | ($0.59) | ($0.59) | ($0.59) |
| Q3 2018 | 1 | ($0.63) | ($0.63) | ($0.63) |
| Q4 2018 | 1 | ($0.33) | ($0.33) | ($0.33) |
| Q1 2019 | 1 | ($0.41) | ($0.41) | ($0.41) |
| Q2 2019 | 1 | ($0.39) | ($0.39) | ($0.39) |
| Q3 2019 | 1 | ($0.38) | ($0.38) | ($0.38) |
| Q4 2019 | 1 | $0.03 | $0.03 | $0.03 |
(Data provided by Zacks Investment Research)
Dividend History for Quotient Limited (NASDAQ:QTNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Quotient Limited (NASDAQ:QTNT)Insider Ownership Percentage: 29.00%
Institutional Ownership Percentage: 38.97%
Insider Trades by Quarter for Quotient Limited (NASDAQ:QTNT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/17/2017 | D J Paul E Cowan | Insider | Sell | 54,460 | $4.06 | $221,107.60 | |
| 7/20/2017 | D J Paul E Cowan | Insider | Sell | 9,420 | $6.11 | $57,556.20 | |
| 7/19/2017 | D J Paul E Cowan | Insider | Sell | 90,580 | $6.39 | $578,806.20 | |
| 7/18/2017 | D J Paul E Cowan | Insider | Sell | 20,580 | $6.29 | $129,448.20 | |
| 7/17/2017 | D J Paul E Cowan | Insider | Sell | 45,032 | $6.57 | $295,860.24 | |
| 8/3/2016 | D J Paul E Cowan | Insider | Buy | 45,455 | $5.50 | $250,002.50 | |
| 8/3/2016 | L John Wilkerson | Director | Buy | 180,000 | $5.50 | $990,000.00 | |
| 6/9/2016 | Jeremy Stackawitz | President | Sell | 15,000 | $10.00 | $150,000.00 | |
| 6/3/2016 | Stephen Unger | CFO | Sell | 14,484 | $9.99 | $144,695.16 | |
| 6/2/2016 | Stephen Unger | CFO | Sell | 8,516 | $10.49 | $89,332.84 | |
| 2/10/2016 | Zubeen Shroff | Director | Buy | 222,222 | $9.00 | $1,999,998.00 | |
| 6/2/2015 | Sarah A Oconnor | Director | Buy | 10,000 | $15.50 | $155,000.00 | |
| 3/13/2015 | Stephen Unger | Insider | Buy | 3,000 | $15.00 | $45,000.00 | |
| 3/3/2015 | Jeremy Stackawitz | President | Sell | 30,000 | $16.80 | $504,000.00 | |
| 3/2/2015 | Jeremy Stackawitz | President | Sell | 4,012 | $16.88 | $67,722.56 | |
| 2/17/2015 | Jeremy Stackawitz | President | Sell | 14,140 | $17.00 | $240,380.00 | |
| 11/28/2014 | Galen Partners V Lp | Major Shareholder | Buy | 157,895 | $9.50 | $1,500,002.50 | |
| 8/7/2014 | Stephen Unger | CFO | Buy | 3,000 | $9.13 | $27,390.00 | |
| 4/30/2014 | Galen Partners V Lp | Major Shareholder | Buy | 312,500 | $8.00 | $2,500,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Quotient Limited (NASDAQ:QTNT)
Latest Headlines for Quotient Limited (NASDAQ:QTNT)
| Source: |
|
| Date | Headline |
|---|
 | Quotient Limited (QTNT) Insider Sells $221,107.60 in Stock
www.americanbankingnews.com - August 17 at 10:28 PM |
| Analysts Set Expectations for Quotient Limited's Q2 2018 Earnings (QTNT)
www.americanbankingnews.com - August 10 at 1:50 PM |
 | Quotient Limited's (QTNT) CEO Paul Cowan on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 6:46 AM |
 | Edited Transcript of QTNT earnings conference call or presentation 8-Aug-17 12:30pm GMT
finance.yahoo.com - August 9 at 6:46 AM |
 | Quotient Limited Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results
globenewswire.com - August 8 at 6:29 AM |
| Quotient Limited (QTNT) Issues Quarterly Earnings Results, Meets Estimates
www.americanbankingnews.com - August 7 at 8:08 PM |
| Quotient Limited (NASDAQ:QTNT) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - July 31 at 10:24 AM |
| Quotient Limited (NASDAQ:QTNT) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - July 26 at 8:06 AM |
| Insider Selling: Quotient Limited (QTNT) Insider Sells 9,420 Shares of Stock
www.americanbankingnews.com - July 24 at 7:50 PM |
| Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ™ and Fiscal First Quarter 2018 Financial Results and Host Conference Call
finance.yahoo.com - July 22 at 8:05 AM |
| Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ™ and Fiscal First Quarter 2018 Financial Results and Host Conference Call
finance.yahoo.com - July 22 at 8:05 AM |
| Quotient Limited (NASDAQ:QTNT) Insider D J. Paul E. Cowan Sells 90,580 Shares
www.americanbankingnews.com - July 19 at 10:14 PM |
| D J. Paul E. Cowan Sells 45,032 Shares of Quotient Limited (NASDAQ:QTNT) Stock
www.americanbankingnews.com - July 19 at 10:14 PM |
| Insider Selling: Quotient Limited (QTNT) Insider Sells 20,580 Shares of Stock
www.americanbankingnews.com - July 19 at 10:14 PM |
| Quotient Limited (QTNT) versus NanoString Technologies (NSTG) Financial Comparison
www.americanbankingnews.com - July 17 at 8:18 PM |
| Lantheus Holdings (LNTH) & Quotient Limited (QTNT) Critical Comparison
www.americanbankingnews.com - July 11 at 12:20 AM |
| Quotient Limited (NASDAQ:QTNT) versus NanoString Technologies (NSTG) Head-To-Head Analysis
www.americanbankingnews.com - July 7 at 8:07 AM |
| Quotient Limited (NASDAQ:QTNT) Lifted to "Sell" at ValuEngine
www.americanbankingnews.com - July 1 at 9:28 AM |
| Quotient and Ortho Clinical Diagnostics to Present Symposium on Role of Extended Phenotyping in Blood Matching at ISBT
finance.yahoo.com - June 20 at 1:38 AM |
| Head to Head Contrast: Quotient Limited (QTNT) & Biocept (BIOC)
www.americanbankingnews.com - June 18 at 8:18 AM |
| Quotient Ltd. :QTNT-US: Earnings Analysis: Q4, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 10:20 PM |
| Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 31 at 12:56 PM |
| Quotient Ltd. :QTNT-US: Earnings Analysis: 2017 By the Numbers : May 30, 2017
finance.yahoo.com - May 30 at 7:07 PM |
| Quotient Ltd to Post Q1 2018 Earnings of ($0.56) Per Share, Jefferies Group Forecasts (QTNT)
www.americanbankingnews.com - May 25 at 9:28 AM |
| Quotient Ltd (QTNT) Forecasted to Earn Q1 2019 Earnings of ($0.40) Per Share
www.americanbankingnews.com - May 24 at 2:38 PM |
| Quotient Ltd (QTNT) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - May 23 at 9:26 AM |
| Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results
finance.yahoo.com - May 22 at 6:34 PM |
| Quotient reports 4Q loss
finance.yahoo.com - May 22 at 6:34 PM |
| Quotient Ltd (QTNT) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - May 17 at 7:48 AM |
| Quotient Limited to Participate in the UBS Global Healthcare Conference
finance.yahoo.com - May 9 at 7:00 PM |
| Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call
finance.yahoo.com - May 9 at 10:52 AM |
| Quotient (QTNT) Receives Daily Media Sentiment Rating of 0.12
www.americanbankingnews.com - May 3 at 11:50 PM |
| Quotient (QTNT) Given News Impact Score of 0.31
www.americanbankingnews.com - April 25 at 7:48 PM |
| Quotient Ltd (QTNT) Sees Large Decline in Short Interest
www.americanbankingnews.com - April 19 at 10:35 AM |
| Quotient (QTNT) Getting Favorable Media Coverage, Analysis Finds
www.americanbankingnews.com - April 18 at 5:22 PM |
| Quotient Ltd (QTNT) Earns Buy Rating from Analysts at BTIG Research
www.americanbankingnews.com - April 18 at 9:47 AM |
| Zacks: Quotient Ltd (QTNT) Given Average Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 3 at 11:37 PM |
 | Quotient Reports Continued Positive MosaiQ™ Performance Evaluation Results
us.rd.yahoo.com - March 30 at 7:41 PM |
| FDA Licenses Eight New Quotient Reagent Products for Sale in the U.S.
us.rd.yahoo.com - March 24 at 8:03 AM |
| Quotient Limited to Participate in the Cowen and Company 37th Annual Health Care Conference
finance.yahoo.com - February 22 at 9:28 AM |
| QUOTIENT LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
biz.yahoo.com - February 15 at 12:15 AM |
| QUOTIENT LTD Financials
finance.yahoo.com - February 11 at 7:30 PM |
| Quotient's (QTNT) CEO Paul Cowan on F3Q 2017 Results - Earnings Call Transcript
seekingalpha.com - February 7 at 10:28 PM |
 | Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Third Quarter Fiscal 2017 Financial Results
www.streetinsider.com - February 6 at 7:34 PM |
| Q3 2017 Quotient Ltd Earnings Release - After Market Close
biz.yahoo.com - February 6 at 8:52 AM |
| Quotient Limited to Report Third Quarter Fiscal 2017 Financial Results and Host Conference Call
finance.yahoo.com - January 24 at 8:21 AM |
| Quotient (QTNT) Gaisn After Positive MosaiQ Blood Grouping Results
www.streetinsider.com - January 6 at 5:47 AM |
| 4:08 pm Quotient Limited reports positive MosaiQ results from performance evaluation study for blood grouping
us.rd.yahoo.com - January 6 at 12:47 AM |
| Quotient Limited to Participate in the 35th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 21 at 8:59 AM |
| What Makes Quotient (QTNT) a Strong Sell?
finance.yahoo.com - November 25 at 12:16 PM |
Quotient Limited (QTNT) Chart for Monday, August, 21, 2017
